Eris Lifesciences buys Strides Shasun#39;s India branded business for Rs 500 crore
newsdepo.com
Strides’ India branded generics business comprises of a portfolio of 130 plus brands in the domains of neurology, psychiatry, nutraceuticals and gastro.Eris Lifesciences buys Strides Shasun#39;s India branded business for Rs 500 crore
Strides’ India branded generics business comprises of a portfolio of 130 plus brands in the domains of neurology, psychiatry, nutraceuticals and gastro. Read more